Back to mobile site

More on BMEA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+14.8% Growth)
- Ratings (8.3 Score)

Upcoming Events

- Earnings (11/3/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Biomea Fusion, Inc. (NQ:BMEA)
Delayed: 2.03 +0.12 (6.28%)
Prev. Close $1.91  
Open$1.90 
52 Wk High$ 
52 Wk Low$ 
Day High$2.05 
Day Low$1.89 
P/E N/A  
EPS$ 
Volume3,290,497 

Friends, Peers and Foes (?): CAR, CVI, FHI, INTC, MRNA (more...)

Sep 3, 2026 08:00 AM Biomea Fusion to Participate in Upcoming Investor Conferences
Aug 24, 2026 09:43 AM H.C. Wainwright on Biomea Fusion Inc. (BMEA) amid 17% Gain: 'Another step toward confirmatory Phase 2 data and T2D development strategy'
Aug 24, 2026 07:03 AM Biomea Fusion completes enrollment in Phase II diabetes trial
Aug 24, 2026 07:00 AM Biomea Fusion Announces Completion of Enrollment in COVALENT-211 Phase II Trial of Icovamenib in Insulin-Deficient Type 2 Diabetes
Aug 13, 2026 07:02 AM Biomea Fusion doses first patient in obesity combo drug study
Aug 13, 2026 07:00 AM Biomea Fusion Announces First Patient Dosed in OPAL Study Evaluating Icovamenib in Combination with Semaglutide in Obesity
Aug 11, 2026 04:48 AM Citi opens 90-day Positive catalyst watch on Biomea Fusion
Aug 5, 2026 06:18 PM Biomea Fusion, Inc. (BMEA) Tops Q2 EPS by 9c
Aug 5, 2026 04:13 PM Form 10-Q Biomea Fusion, Inc. For: Jun 30
Aug 5, 2026 04:11 PM Form 8-K Biomea Fusion, Inc. For: Aug 05
View All Articles

Entities mentioned with BMEA

View All Entities